Replies to post #235161 on Avid Bioservices Inc (CDMO)

[tech0200]

>CALICO gives us a Line of Credit for $2 Billion for expenses and R&D.

We give them 175 Million shares or 35% of total authorized shares<



What will that do the pps overall? Do we as shareholders see any pps appreciation?

Was there ever a deal like this would be deal, giving shares away at a superdepressed price? Or is the would be partner going to pay something like $10 per share?

What's wrong with a deal like all of the other conventional deals where the partners gives a few billions to this little puppy?

Wasn't AbbVie going to give 2 billions in the deal right before the botched trial?

Maybe the company is going to do with these shares the same thing they did before and are still doing? ATM spigot to raise cash to go it alone?

[realist1]

RE "CALICO gives us a Line of Credit for $2 Billion for expenses and R&D
We give them 175 Million shares or 35% of total authorized "

$2 billion / 500 million shares = $4 per share AKA a lousy 80 pennies pre-reverse. A LOSS for long term shareholders.

DILUTION KILLS absolutely, and absolute power over issuing shares absolutely kills PPS.